Wil Helmus schreef op 22 juni 2023 12:50:
PB, geen nieuws over een eventuele aandelensplitsing. Wel een nieuw directielid:
“We are delighted to announce the appointment of Dr. Ulmer-Eilfort to our Supervisory Board,” said Dr. Thomas Hecht, Chairman of Affimed’s Supervisory Board. “Constanze brings a wealth of legal expertise and a deep understanding of the biotech and healthcare industries, making her an invaluable addition to our team. With her extensive background, we expect Constanze will provide critical insights and guidance to the Company on matters related to corporate governance, corporate strategy, compliance and ESG, among others.”
Zal ze binnen gehaald zijn om de overname van Affimed in goede banen te leiden?;-)